Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

STEP 2

Novo Nordisk · Phase 3 · Completed · Enrollment 1210

NCT03552757

EudraCT 2017-003414-10

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Semaglutide 1.0 mg128 participants54 participants88 participantsn/r1
Semaglutide 2.4 mg135 participants86 participants86 participantsn/r1
Semaglutide placebo I/II37 participants11 participants48 participantsn/r1

A count stays a count. This page does not turn a count into a percent.